Filtered By:
Condition: Hemorrhagic Stroke
Cancer: Brain Cancers
This page shows you your search results in order of date. This is page number 7.
Order by Relevance | Date
Total 297 results found since Jan 2013.
Clinical Significance of Delirium With Catatonic Signs in Patients With Neurological Disorders
CONCLUSIONS: Delirium is a common complication of neurological diseases, and it can coexist with catatonia. The recognition of catatonic delirium has clinical significance in terms of etiology, as it was significantly associated with viral and anti-NMDAR encephalitis.PMID:35040665 | DOI:10.1176/appi.neuropsych.18120364
Source: Journal of Neuropsychiatry and Clinical Neurosciences - January 18, 2022 Category: Psychiatry Authors: Jesus Ramirez-Bermudez Angela Medina-Gutierrez Heraclides Gomez-Cianca Patricia Arias Andres P érez-Gonzalez Paulina Ang élica Lebrija-Reyes Mariana Espinola-Nadurille Luis Carlos Aguilar-Venegas Carmen Ojeda-L ópez Miguel Restrepo-Mart ínez Leo Bayli Source Type: research
Multi-disciplinary Approach for Drug and Gene Delivery Systems to the Brain
AAPS PharmSciTech. 2021 Dec 3;23(1):11. doi: 10.1208/s12249-021-02144-1.ABSTRACTDrug delivery into the brain has for long been a huge challenge as the blood-brain barrier (BBB) offers great resistance to entry of foreign substances (with drugs inclusive) into the brain. This barrier in healthy individuals is protective to the brain, disallowing noxious substances present in the blood to get to the brain while allowing for the exchange of small molecules into the brain by diffusion. However, BBB is disrupted under certain disease conditions, such as cerebrovascular diseases including acute ischemic stroke and intracerebral ...
Source: AAPS PharmSciTech - December 4, 2021 Category: Drugs & Pharmacology Authors: Nkafu Bechem Ndemazie Andriana Inkoom Ellis Fualefeh Morfaw Taylor Smith Monica Aghimien Dexter Ebesoh Edward Agyare Source Type: research
Janssen to Present the Strength and Promise of its Hematologic Malignancies Portfolio and Pipeline at ASH 2021
RARITAN, N.J., November 4, 2021 – The Janssen Pharmaceutical Companies of Johnson & Johnson announced today that more than 45 company-sponsored abstracts, including 11 oral presentations, plus more than 35 investigator-initiated studies will be featured at the American Society of Hematology (ASH) Annual Meeting and Exposition. ASH is taking place at the Georgia World Congress Center in Atlanta and virtually from December 11-14, 2021.“We are committed to advancing the science and treatment of hematologic malignancies and look forward to presenting the latest research from our robust portfolio and pipeline during ASH...
Source: Johnson and Johnson - November 5, 2021 Category: Pharmaceuticals Tags: Innovation Source Type: news
Decompressive craniectomy: A salvage treatment for patients with central nervous system tumors
CONCLUSION: Our data show that in some selected cases DC is a viable option as a salvage treatment for patients with intracranial tumors.PMID:34665170 | DOI:10.24875/CIRU.20000808
Source: Cirugia y Cirujanos - October 19, 2021 Category: Surgery Authors: Javier A Jacobo Rafael Vazquez-Gregorio Sergio Moreno-Jimenez Sonia Mejia-Perez Source Type: research
